Viewing Study NCT06340334


Ignite Creation Date: 2025-12-25 @ 2:30 AM
Ignite Modification Date: 2025-12-27 @ 11:40 PM
Study NCT ID: NCT06340334
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-04-01
First Post: 2024-03-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Tegoprazan Dual Therapy and Furazolidone-based Bismuth Quadruple Therapy for Helicobacter Pylori Eradication: A Prospective, Multicenter, Open-label, Randomized Controlled Clinical Study
Sponsor: Nanjing First Hospital, Nanjing Medical University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Helicobacter Pylori Infection View
None Tegoprazan View
None Furazolidone View
Keywords: